BCR-ABL1 mutation ≠ ponatinib resistance

Blood. 2016 Feb 11;127(6):666-7. doi: 10.1182/blood-2015-12-685149.
No abstract available

Publication types

  • Comment

MeSH terms

  • Drug Resistance, Neoplasm / genetics*
  • Fusion Proteins, bcr-abl / genetics*
  • Humans
  • Imidazoles / therapeutic use*
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Mutation / physiology*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyridazines / therapeutic use*

Substances

  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyridazines
  • Fusion Proteins, bcr-abl